Company Filing History:
Years Active: 2003
Title: David Melican: Innovator in Embryo Transfer Technology
Introduction
David Melican is a notable inventor based in Fiskdale, MA (US). He has made significant contributions to the field of reproductive technology, particularly in the area of embryo transfer methods. His innovative work has the potential to advance the science of cloning and transgenic mammals.
Latest Patents
David Melican holds a patent for "Methods of reconstructed goat embryo transfer." This invention features methods of producing a mammal, such as a cloned or transgenic mammal. The method includes maintaining a reconstructed embryo in culture until the embryo reaches the 2 to 8 cell stage of embryogenesis. It also involves transferring the embryo at this stage into a recipient mammal and allowing it to develop into a fully formed mammal. This patent highlights Melican's expertise in the intricate processes of embryonic development.
Career Highlights
Throughout his career, David Melican has been associated with Genzyme Transgenics Corporation, where he has applied his knowledge and skills to further research in genetic engineering and reproductive technologies. His work has contributed to the understanding and application of advanced techniques in the field.
Collaborations
David has collaborated with esteemed colleagues such as Yann Echelard and Esmail Behbodi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biotechnology.
Conclusion
David Melican's contributions to the field of embryo transfer technology exemplify the impact of innovative thinking in science. His patent and work at Genzyme Transgenics Corporation reflect a commitment to advancing reproductive technology. His efforts continue to pave the way for future developments in cloning and transgenic research.